Text Messaging and Home Blood Pressure Monitoring for Patients with Uncontrolled Hypertension: Proposal for a Feasibility Pilot Randomized Controlled Trial.

SMS health disparities home blood pressure monitoring hypertension medication adherence telehealth

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
14 May 2021
Historique:
received: 05 04 2020
accepted: 24 02 2021
revised: 15 09 2020
entrez: 14 5 2021
pubmed: 15 5 2021
medline: 15 5 2021
Statut: epublish

Résumé

A decrease in blood pressure, even modestly (ie, 2 mmHg), lowers cardiovascular morbidity and mortality. Low patient adherence to antihypertensive medication is the most significant modifiable patient-related barrier to achieving controlled blood pressure. Preliminary studies have shown that SMS text messaging and home blood pressure monitoring (HBPM) can be effective in promoting medication adherence and blood pressure control. The best strategy to engage with older patients of low socioeconomic status who are low adopters of technology and disproportionally affected by uncontrolled hypertension is still unknown. The objective of this study is to improve blood pressure control in the older, low socioeconomic status population. The study will test two aims: First, we aim to evaluate the feasibility of conducting a randomized controlled trial by using an SMS-based approach among nonadherent, older patients of low socioeconomic status who have uncontrolled hypertension. Feasibility will be assessed in terms of recruitment rates per month (primary outcome); patient acceptability will be evaluated by monitoring retention rates and SMS response rates and using the validated Systems Usability Scale (secondary outcomes). Second, we aim to estimate the effects of the SMS approach on lowering blood pressure and adherence to antihypertensive medications. We will recruit 24 patients of low socioeconomic status with uncontrolled hypertension (systolic BP>140 mmHg or diastolic BP>90 mmHg) showing low medication adherence and taking at least two antihypertensives, who have presented to two outpatient clinics of Wake Forest Baptist Health (Winston Salem, North Carolina, USA). Participants will be randomly assigned to either SMS and HBPM (n=12) or usual care and HBPM (n=12) intervention. Clinicians adjusting the patients' medications will be blinded to the study assignment. Text messages will be sent from a secure platform to assess medication adherence and HBPM on a weekly basis. The content and delivery frequency of the proposed SMS intervention are based on input from three focus groups conducted in Spring 2019. Participants in both study arms will receive education on HBPM and using an HBPM device. We hypothesize that we will successfully recruit 24 participants and the intervention will be acceptable to the participants. It will also improve medication adherence (assessed by question Medication Adherence Questionnaire scores) and blood pressure control. Our study was funded in July 2020. As of May 2021, we have enrolled 6 participants. Our findings will help design a larger efficacy trial to advance the field of eHealth delivery systems particularly for older adults of low socioeconomic status. This study addresses a highly significant topic and targets a population of high morbidity and mortality that has been traditionally underrepresented in clinical trials. ClinicalTrials.gov NCT03596242; https://clinicaltrials.gov/ct2/show/NCT03596242. PRR1-10.2196/18984.

Sections du résumé

BACKGROUND BACKGROUND
A decrease in blood pressure, even modestly (ie, 2 mmHg), lowers cardiovascular morbidity and mortality. Low patient adherence to antihypertensive medication is the most significant modifiable patient-related barrier to achieving controlled blood pressure. Preliminary studies have shown that SMS text messaging and home blood pressure monitoring (HBPM) can be effective in promoting medication adherence and blood pressure control. The best strategy to engage with older patients of low socioeconomic status who are low adopters of technology and disproportionally affected by uncontrolled hypertension is still unknown.
OBJECTIVE OBJECTIVE
The objective of this study is to improve blood pressure control in the older, low socioeconomic status population. The study will test two aims: First, we aim to evaluate the feasibility of conducting a randomized controlled trial by using an SMS-based approach among nonadherent, older patients of low socioeconomic status who have uncontrolled hypertension. Feasibility will be assessed in terms of recruitment rates per month (primary outcome); patient acceptability will be evaluated by monitoring retention rates and SMS response rates and using the validated Systems Usability Scale (secondary outcomes). Second, we aim to estimate the effects of the SMS approach on lowering blood pressure and adherence to antihypertensive medications.
METHODS METHODS
We will recruit 24 patients of low socioeconomic status with uncontrolled hypertension (systolic BP>140 mmHg or diastolic BP>90 mmHg) showing low medication adherence and taking at least two antihypertensives, who have presented to two outpatient clinics of Wake Forest Baptist Health (Winston Salem, North Carolina, USA). Participants will be randomly assigned to either SMS and HBPM (n=12) or usual care and HBPM (n=12) intervention. Clinicians adjusting the patients' medications will be blinded to the study assignment. Text messages will be sent from a secure platform to assess medication adherence and HBPM on a weekly basis. The content and delivery frequency of the proposed SMS intervention are based on input from three focus groups conducted in Spring 2019. Participants in both study arms will receive education on HBPM and using an HBPM device. We hypothesize that we will successfully recruit 24 participants and the intervention will be acceptable to the participants. It will also improve medication adherence (assessed by question Medication Adherence Questionnaire scores) and blood pressure control.
RESULTS RESULTS
Our study was funded in July 2020. As of May 2021, we have enrolled 6 participants.
CONCLUSIONS CONCLUSIONS
Our findings will help design a larger efficacy trial to advance the field of eHealth delivery systems particularly for older adults of low socioeconomic status. This study addresses a highly significant topic and targets a population of high morbidity and mortality that has been traditionally underrepresented in clinical trials.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT03596242; https://clinicaltrials.gov/ct2/show/NCT03596242.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
PRR1-10.2196/18984.

Identifiants

pubmed: 33988513
pii: v10i5e18984
doi: 10.2196/18984
pmc: PMC8164117
doi:

Banques de données

ClinicalTrials.gov
['NCT03596242']

Types de publication

Journal Article

Langues

eng

Pagination

e18984

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001420
Pays : United States

Informations de copyright

©Claudia L Campos, Deanna Jones, Beverly M Snively, Michael Rocco, Carolyn Pedley, Sara Atwater, Justin B Moore. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 14.05.2021.

Références

Ann Pharmacother. 2004 Sep;38(9):1363-8
pubmed: 15238622
J Diabetes Sci Technol. 2007 Jan;1(1):130-2
pubmed: 19888392
Sociology. 2015 Jun;49(3):488-504
pubmed: 26038612
J Am Heart Assoc. 2018 Jun 1;7(11):
pubmed: 29858369
BMJ Open. 2015 Mar 16;5(3):e005582
pubmed: 25776041
J Hypertens. 2012 Jul;30(7):1289-99
pubmed: 22499289
PLoS Med. 2017 Sep 19;14(9):e1002389
pubmed: 28926573
Med Care. 1986 Jan;24(1):67-74
pubmed: 3945130
Med Care. 2005 Jun;43(6):521-30
pubmed: 15908846
Med J Aust. 2006 Nov 6;185(9):487-9
pubmed: 17137452
J Am Coll Cardiol. 2005 Sep 6;46(5):743-51
pubmed: 16139119
JMIR Mhealth Uhealth. 2019 Jan 08;7(1):e12269
pubmed: 30622092
Health Expect. 2012 Dec;15(4):424-32
pubmed: 21711471
Lancet. 2005 Mar 19-25;365(9464):1099-104
pubmed: 15781105
J Behav Med. 2008 Dec;31(6):453-62
pubmed: 18784996
Ann Intern Med. 2013 Aug 6;159(3):185-94
pubmed: 23922064
Med Clin North Am. 2009 May;93(3):753-69
pubmed: 19427503
MMWR Morb Mortal Wkly Rep. 2016 Sep 16;65(36):967-76
pubmed: 27632693
Am J Hypertens. 2015 Oct;28(10):1209-21
pubmed: 25725092
Circulation. 2018 May 15;137(20):2166-2178
pubmed: 29760227
Eur Heart J. 2013 Oct;34(38):2940-8
pubmed: 23907142
Blood Press Monit. 2006 Oct;11(5):257-67
pubmed: 16932035
Hypertension. 2018 Jun;71(6):1269-1324
pubmed: 29133354
Front Pharmacol. 2019 Mar 01;10:168
pubmed: 30930769
Circulation. 2016 Feb 9;133(6):555-6
pubmed: 26769741
Stat Methods Med Res. 2016 Jun;25(3):1057-73
pubmed: 26092476
JMIR Cardio. 2017 Jul 27;1(2):e2
pubmed: 31758763
Mayo Clin Proc. 2011 Apr;86(4):304-14
pubmed: 21389250

Auteurs

Claudia L Campos (CL)

Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.

Deanna Jones (D)

Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.

Beverly M Snively (BM)

Department of Biostatistics and Data Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, United States.

Michael Rocco (M)

Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.

Carolyn Pedley (C)

Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.

Sara Atwater (S)

Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.

Justin B Moore (JB)

Department of Family and Community Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Department of Implementation Science, Wake Forest School of Medicine, Winston-Salem, NC, United States.

Classifications MeSH